|
Q4 2023
|
34 |
586,726 |
ALPN, CYTK, URGN, PLRX
|
13F-HR
|
2/14/2024 |
000117266124001436 |
|
Q3 2023
|
42 |
549,036 |
URGN, ALPN, PLRX, PCVX
|
13F-HR
|
11/14/2023 |
000117266123004025 |
|
Q2 2023
|
40 |
510,829 |
ALPN, RARE, PCVX, PLRX
|
13F-HR
|
8/14/2023 |
000117266123003165 |
|
Q1 2023
|
44 |
509,321 |
PLRX, XENE, ALPN, RARE
|
13F-HR
|
5/15/2023 |
000117266123002293 |
|
Q4 2022
|
42 |
510,185 |
PCVX, XENE, RAPT, ALPN
|
13F-HR
|
2/14/2023 |
000117266123001300 |
|
Q3 2022
|
40 |
415,311 |
XENE, JAZZ, PNT, ALPN
|
13F-HR
|
11/14/2022 |
000117266122002573 |
|
Q2 2022
|
35 |
416,964 |
XENE, JAZZ, CYTK, TVTX
|
13F-HR
|
8/15/2022 |
000117266122001993 |
|
Q1 2022
|
30 |
413,781 |
EXEL, XENE, TVTX, BCYC
|
13F-HR
|
5/16/2022 |
000117266122001465 |
|
Q4 2021
|
36 |
450,122 |
ARNA, EXEL, XENE, TVTX
|
13F-HR
|
2/14/2022 |
000117266122000487 |
|
Q3 2021
|
36 |
429,472 |
EXEL, ARNA, KDMN, BCAB
|
13F-HR
|
11/15/2021 |
000117266121002382 |
|
Q2 2021
|
30 |
476,717 |
MGNX, RCKT, ARNA, UTHR
|
13F-HR
|
8/16/2021 |
000117266121001868 |
|
Q1 2021
|
28 |
483,855 |
MGNX, RCKT, IOVA, SAGE
|
13F-HR
|
5/17/2021 |
000117266121001313 |
|
Q4 2020
|
33 |
615,668 |
GWPH, IOVA, SAGE, ACAD
|
13F-HR
|
2/16/2021 |
000117266121000726 |
|
Q3 2020
|
34 |
1,111,643 |
IOVA, SAGE, ACAD, ARNA
|
13F-HR
|
11/16/2020 |
000117266120002326 |
|
Q2 2020
|
36 |
1,251,009 |
CNST, IOVA, ZYMEWORKS INC, ACAD
|
13F-HR
|
8/14/2020 |
000117266120001861 |
|
Q1 2020
|
36 |
957,136 |
ACAD, ZYMEWORKS INC, PTCT, IOVA
|
13F-HR
|
5/15/2020 |
000117266120001361 |
|
Q4 2019
|
37 |
1,148,462 |
IOVA, ZYMEWORKS INC, PTCT, AXSM calls
|
13F-HR
|
2/14/2020 |
000117266120000830 |
|
Q3 2019
|
41 |
1,088,642 |
IOVA, ZGNX, ACAD, BOLD
|
13F-HR
|
11/15/2019 |
000093041319002849 |
|
Q2 2019
|
30 |
900,806 |
IOVA, PTCT, ZGNX, BOLD
|
13F-HR
|
8/14/2019 |
000093041319002313 |
|
Q1 2019
|
40 |
1,010,320 |
PTCT, ZGNX, GLOBAL BLOOD THERAPEUTICS INC, BOLD
|
13F-HR
|
5/14/2019 |
000093041319001676 |
|
Q4 2018
|
40 |
791,189 |
BCRX, IOVA, GLOBAL BLOOD THERAPEUTICS INC, XLRN
|
13F-HR
|
2/15/2019 |
000093041319000592 |
|
Q3 2018
|
30 |
641,666 |
BCRX, XLRN, LRMR, IOVA
|
13F-HR
|
11/14/2018 |
000093041318003323 |
|
Q2 2018
|
38 |
721,561 |
PTCT, KURA, IOVA, BCRX
|
13F-HR
|
8/14/2018 |
000093041318002592 |
|
Q1 2018
|
37 |
673,402 |
IOVA, ARNA, KURA, PTCT
|
13F-HR
|
5/14/2018 |
000093041318001815 |
|
Q4 2017
|
39 |
586,066 |
ZGNX, ARNA, KURA, SAGE
|
13F-HR
|
2/14/2018 |
000093041318000474 |
|
Q3 2017
|
37 |
514,030 |
ZGNX, UTHR calls, ARNA, CNCE
|
13F-HR
|
11/14/2017 |
000093041317003778 |
|
Q2 2017
|
38 |
558,190 |
ARNA, ADMS, VNDA, ZGNX
|
13F-HR
|
8/14/2017 |
000093041317002918 |
|
Q1 2017
|
37 |
503,510 |
ADMS, CNCE, SGYPQ, VNDA
|
13F-HR
|
5/15/2017 |
000093041317002121 |
|
Q4 2016
|
35 |
486,757 |
ADMS, FOMX, VNDA, SGYPQ
|
13F-HR
|
2/14/2017 |
000093041317000546 |
|
Q3 2016
|
35 |
392,073 |
VNDA, ADMS, SGYPQ, ZGNX
|
13F-HR
|
11/14/2016 |
000093041316008703 |
|
Q2 2016
|
39 |
349,225 |
ADMS, VNDA, SGYPQ, EXEL
|
13F-HR
|
8/15/2016 |
000093041316007885 |
|
Q1 2016
|
33 |
278,668 |
ADMS, FPRX, VNDA, ZGNX
|
13F-HR
|
5/16/2016 |
000093041316007144 |
|
Q4 2015
|
25 |
238,298 |
ADMS, FPRX, ZGNX, VNDA
|
13F-HR
|
2/16/2016 |
000093041316005528 |
|
Q3 2015
|
36 |
252,823 |
VNDA, FPRX, CNXR, ADMS
|
13F-HR
|
11/16/2015 |
000093041315004329 |
|
Q2 2015
|
34 |
256,525 |
CNXR, ADMS, VNDA, FPRX
|
13F-HR
|
8/14/2015 |
000093041315003355 |
|
Q1 2015
|
33 |
227,217 |
CNXR, HPTX, VNDA, OFIX
|
13F-HR
|
5/15/2015 |
000093041315002517 |
|
Q4 2014
|
28 |
207,762 |
CNXR, HPTX, ALIM, OCRX
|
13F-HR
|
2/17/2015 |
000093041315000640 |
|
Q3 2014
|
37 |
232,821 |
HPTX, NBIX, INFI, ALIM
|
13F-HR
|
11/14/2014 |
000093041314004572 |
|
Q2 2014
|
38 |
224,814 |
NBIX, HPTX, DSCI, THOR
|
13F-HR
|
8/14/2014 |
000093041314003671 |
|
Q1 2014
|
36 |
191,481 |
FURX, HPTX, PAIN THERAPEUTICS INC, ALIM
|
13F-HR
|
5/15/2014 |
000093041314002534 |
|
Q4 2013
|
28 |
141,604 |
HPTX, PAIN THERAPEUTICS INC, FURX, SUNSHINE HEART INC
|
13F-HR
|
2/14/2014 |
000093041314000601 |